한국어
English
日本語
中文(简体)
Erlidazong (Apalutamide)
60mg
Tablet · Prescription medication
Korea Janssen Co., Ltd.
Apalutamide is an antineoplastic agent used in the treatment of prostate cancer that inhibits the growth of cancer cells.
MFDS ingredient code M280179
Apalutamide belongs to the class of non-steroidal androgen receptor inhibitors. It is primarily used in the treatment of prostate cancer and is utilized to block the action of male hormones necessary for cancer cell growth.
Apalutamide binds to androgen receptors in prostate cancer cells, preventing male hormones from attaching to the receptors. This blocks the signaling that allows cancer cells to grow and proliferate, slowing the progression of the cancer.
Approved uses differ by product. Check each product's information for its actual use.
Apalutamide binds more strongly to the receptors than conventional androgen receptor antagonists and is characterized by delaying the development of resistance. Additionally, it has a lower ability to cross the blood-brain barrier, resulting in relatively fewer central nervous system side effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.